| Entry |
|
| Name |
Neladalkib (USAN/INN) |
| Formula |
C23H22ClFN6O
|
| Exact mass |
452.1528
|
| Mol weight |
452.91
|
| Structure |

|
| Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG03136 ALK inhibitor
|
| Efficacy |
Antineoplastic, Anaplastic lymphoma kinase (ALK) inhibitor |
| Comment |
Treatment of non-small cell lung cancer and solid tumors harboring ALK rearrangement or activating ALK mutation
|
| Target |
|
| Pathway |
|
| Interaction |
|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG03136 ALK inhibitor
D13079 Neladalkib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
ALK family
ALK (CD246)
D13079 Neladalkib (USAN/INN)
|
| Other DBs |
|
| LinkDB |
|
| KCF data |
ATOM 32
1 C8x C 8.6800 -14.2100
2 C8y C 8.6800 -15.6100
3 C8x C 9.8700 -16.3100
4 C8y C 11.1300 -15.6100
5 C8y C 11.1300 -14.2100
6 C8x C 9.8700 -13.5100
7 X F 7.4900 -16.3100
8 C8y C 12.3200 -13.5100
9 C8y C 13.7200 -13.5100
10 C8x C 14.1400 -12.1800
11 N4y N 13.0200 -11.3400
12 N5x N 11.9000 -12.1800
13 C1x C 14.5476 -14.6392
14 C1y C 12.3366 -16.3200
15 O2x O 12.3366 -17.7200
16 C1a C 13.5436 -15.6296
17 C8y C 13.5323 -18.4102
18 C8y C 14.2075 -19.6423
19 N5x N 15.6072 -19.6697
20 C8x C 16.3308 -18.4713
21 C8y C 15.6547 -17.2453
22 C8x C 14.2550 -17.2179
23 C8y C 15.9525 -14.6257
24 C8y C 16.3837 -15.9643
25 N4y N 17.7916 -15.9702
26 N5x N 18.2323 -14.6331
27 C8y C 17.0968 -13.8008
28 C1a C 13.0200 -9.9400
29 X Cl 17.1025 -12.3902
30 C1b C 18.6009 -17.0941
31 C1a C 20.0141 -17.0918
32 N1a N 13.4705 -20.8587
BOND 36
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 5 8 1
9 8 9 1
10 9 10 2
11 10 11 1
12 11 12 1
13 8 12 2
14 9 13 1
15 4 14 1
16 14 15 1
17 14 16 1 #Up
18 15 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 17 22 1
25 13 23 1
26 23 24 2
27 24 25 1
28 25 26 1
29 26 27 2
30 23 27 1
31 24 21 1
32 11 28 1
33 27 29 1
34 25 30 1
35 30 31 1
36 18 32 1
|